FDA.reportPublic FDA data

ATOZCUP TATTOO NUMBING

Manufacturer
Dongguan City Bobiter Electronic Technology Co., Ltd
Effective date
2023-12-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:05:03

Label at a glance#

ProductATOZCUP TATTOO NUMBING
Active ingredientLIDOCAINE
Label structure12 sections

Dosage and administration

1.Wash and exfoliate the area to be treated. 2.Dry the area completely. 3.Apply this numbing cream(2mm thick) to the area and rub in thoroughly 4.Cover with cling film. 5.leave the cream and wrap in place for 60-90 minutes before procedure. 6.After the wrapping time,remove thecling film and wipe the cream away

Storage and handling

*Always keep tihgtly closed *Store at temperatures between 59°F-86°F(15°C-30°C) *Protectfrom freezing

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 5%

Purpose

OTC - PURPOSE SECTION

local anesthetic

Use

INDICATIONS & USAGE SECTION

For temporary relief of local discomfort, itching, pain,soreness or burning of the skin

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

Do not exceed the recommended daily dosage unless directed by a doctor.

OTC - WHEN USING SECTION

When using Avoid contact with eyes. If this happens, rinse thoroughly with water.

OTC - STOP USE SECTION

lf allergy occurs such as redness,irritation,swelling,pain or other symptoms become severe Stop use and get to a doctor.If symptoms persist for more than 7days or subside but occur again within3 days,stop use and consult aphysician.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. 

Directions

DOSAGE & ADMINISTRATION SECTION

1.Wash and exfoliate the area to be treated.
2.Dry the area completely.

3.Apply this numbing cream(2mm thick) to the area and rub in thoroughly

4.Cover with cling film.

5.leave the cream and wrap in place for 60-90 minutes before procedure.

6.After the wrapping time,remove thecling film and wipe the cream away

Storage and handling

STORAGE AND HANDLING SECTION

*Always keep tihgtly closed

*Store at temperatures between 59°F-86°F(15°C-30°C)

*Protectfrom freezing

Inactive ingredients

INACTIVE INGREDIENT SECTION

Lecithin(Soybean)，Propylene Glycol，Tocopheryl Acctate,Aloe Vera，Water，Carbomer,Menthol，Triethanolamine

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1534792lidocaine 5 % Topical CreamPSN2
1534792lidocaine 50 MG/ML Topical CreamSCD2
1534792lidocaine 5 % Topical CreamSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
070fbed5-7088-434a-a7ce-f2a64d8d40acProduct name220260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80fProduct name520250819
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
7d755fa1-1087-4dcd-98f0-6d4bba479a57Product name320210602
aed701d5-9c75-dfaf-7154-cde46179faeaProduct name920200313
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508
49fa150c-f0de-cce7-3d9c-993ed81c5698Product name120140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ffProduct name120140508
9137811f-f279-8640-5aeb-99fa2145d64dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83706-001-012025-01-30C16284748780-12cef2736-6af2-d83d-e063-dadaa90ab31f05eea032-da99-5d18-e063-6394a90a9fcc

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83706-001-01ATOZCUP TATTOO NUMBING10 g in 1 BOTTLECREAM102
83706-001-01ATOZCUP TATTOO NUMBING1 in 1 PACKAGECREAM12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83706-001ATOZCUP TATTOO NUMBING (LIDOCAINE) CREAM [DONGGUAN CITY BOBITER ELECTRONIC TECHNOLOGY CO., LTD]22 package rows20231221_05eea032-da99-5d18-e063-6394a90a9fcc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83706-00183706-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
NameUNIIKind
PROPYLENE GLYCOL6DC9Q167V3IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208IACT
ALOE VERA LEAFZY81Z83H0XIACT
WATER059QF0KO0RIACT
LECITHIN, SOYBEAN1DI56QDM62IACT
.ALPHA.-TOCOPHEROL ACETATE9E8X80D2L0IACT
MENTHOL, UNSPECIFIED FORML7T10EIP3AIACT
TROLAMINE9O3K93S3TKIACT
LIDOCAINE98PI200987ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0cfcc9b3-6ea0-9eb3-e063-6394a90a3ca905eea032-da99-5d18-e063-6394a90a9fcc2023-12-20WarningsExact identifier
spl id: 0cfcc9b3-6ea0-9eb3-e063-6394a90a3ca9
spl set id: 05eea032-da99-5d18-e063-6394a90a9fcc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.